GENEVA, Nov. 6 -- CAVALRY BIOSCIENCES, INC. filed a patent application (US2026/026142) for “IGF-2 FOR TREATMENT OF MEIBOMIAN GLAND DYSFUNCTION”. With publication no. WO/2026/231989, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/65
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....